Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice

被引:45
作者
Fassan, Matteo [1 ]
Scarpa, Aldo [2 ,3 ]
Remo, Andrea [4 ]
De Maglio, Giovanna [5 ]
Troncone, Giancarlo [6 ]
Marchetti, Antonio [7 ]
Doglioni, Claudio [8 ,9 ]
Ingravallo, Giuseppe [10 ]
Perrone, Giuseppe [11 ]
Parente, Paola [12 ]
Luchini, Claudio [3 ]
Mastracci, Luca [13 ,14 ]
机构
[1] Univ Padua, Dept Med DIMED, Surg Pathol Unit, Padua, Italy
[2] Univ Verona, ARC NET Res Ctr, Verona, Italy
[3] Univ & Hosp Trust Verona, Dept Diagnost & Publ Hlth, Sect Pathol, Piazzale LA Scuro 10, I-37134 Verona, VR, Italy
[4] ULSS9 Scaligera, Pathol Unit, Serv Dept, Verona, Italy
[5] Univ Hosp Udine, Dept Pathol, Udine, Italy
[6] Federico II Univ Med Sch Naples, Dept Publ Hlth, Naples, Italy
[7] Univ G dAnnunzio, Ctr Predict Mol Med, Ctr Excellence Aging & Translat Med, Chieti, Italy
[8] Vita & Salute Univ, Milan, Italy
[9] IRCCS, Pancreas Translat & Clin Res Ctr, Pathol Unit, San Raffaele Sci Inst, Milan, Italy
[10] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Pathol Anat, Bari, Italy
[11] Campus Biomed Univ, Dept Pathol, Rome, Italy
[12] Fdn IRCCS Osped Casa Sollievo Sofferenza, Pathol Unit, San Giovanni Rotondo, FG, Italy
[13] San Martino IRCCS Hosp, Anat Pathol, Genoa, Italy
[14] Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, Anat Pathol, Genoa, Italy
关键词
prognostic markers; predictive markers; targeted therapy; molecular pathology; immunohistochemistry; METASTATIC COLORECTAL-CANCER; MISMATCH REPAIR DEFICIENCY; EPSTEIN-BARR-VIRUS; OF-AMERICAN-PATHOLOGISTS; HER2 SCORING SYSTEM; MICROSATELLITE INSTABILITY; GASTRIC-CANCER; LYNCH-SYNDROME; BRAF MUTATION; MOLECULAR CHARACTERIZATION;
D O I
10.32074/1591-951X-158
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The pathologist emerged in the personalized medicine era as a central actor in the definition of the most adequate diagnostic and therapeutic algorithms. In the last decade, gastrointestinal oncology has seen a significantly increased clinical request for the integration of novel prognostic and predictive biomarkers in histopathological reports. This request couples with the significant contraction of invasive sampling of the disease, thus conferring to the pathologist the role of governor for both proper pathologic characterization and customized processing of the biospecimens. This overview will focus on the most commonly adopted immunohistochemical and molecular biomarkers in the routine clinical characterization of gastrointestinal neoplasms referring to the most recent published recommendations, guidelines and expert opinions.
引用
收藏
页码:248 / 259
页数:12
相关论文
共 112 条
[1]   Programmed cell death ligand-1 (PD-L1) expression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies [J].
Ahn, Soomin ;
Lee, Yangkyu ;
Kim, Ji-Won ;
Lee, Jong-Chan ;
Hwang, Jin-Hyeok ;
Yoon, Yoo-Seok ;
Cho, Jai Young ;
Han, Ho-Seong ;
Choi, YoungRok ;
Kim, Haeryoung .
HISTOPATHOLOGY, 2019, 75 (04) :526-536
[2]   HER2 Status in Gastric Cancer: Comparison between Primary and Distant Metastatic Disease [J].
Amato, Michelina ;
Perrone, Giuseppe ;
Righi, Daniela ;
Pellegrini, Claudio ;
Rabitti, Carla ;
Di Matteo, Francesco ;
Crucitti, Pierfilippo ;
Caputo, Damiano ;
Coppola, Roberto ;
Tonini, Giuseppe ;
Santini, Daniele ;
Muda, Andrea Onetti .
PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (01) :55-61
[3]   Broadening the therapeutic horizon of advanced biliary tract cancer through molecular characterisation [J].
Athauda, Avani ;
Fong, Caroline ;
Lau, David K. ;
Javle, Milind ;
Abou-Alfa, Ghassan K. ;
Morizane, Chigusa ;
Steward, Keith ;
Chau, Ian .
CANCER TREATMENT REVIEWS, 2020, 86
[4]  
Bang YJ, 2010, LANCET, V376, P1302
[5]   Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma [J].
Bao, Fei ;
Panarelli, Nicole C. ;
Rennert, Hanna ;
Sherr, David L. ;
Yantiss, Rhonda K. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2010, 34 (12) :1798-1804
[6]  
Barras David, 2015, Biomark Cancer, V7, P9, DOI 10.4137/BIC.S25248
[7]   HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma Guideline From the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology [J].
Bartley, Angela N. ;
Washington, Mary Kay ;
Ventura, Christina B. ;
Ismaila, Nofisat ;
Colasacco, Carol ;
Benson, Al B., III ;
Carrato, Alfredo ;
Gulley, Margaret L. ;
Jain, Dhanpat ;
Kakar, Sanjay ;
Mackay, Helen J. ;
Streutker, Catherine ;
Tang, Laura ;
Troxell, Megan ;
Ajani, Jaffer A. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2016, 140 (12) :1345-1363
[8]   Comprehensive molecular characterization of gastric adenocarcinoma [J].
Bass, Adam J. ;
Thorsson, Vesteinn ;
Shmulevich, Ilya ;
Reynolds, Sheila M. ;
Miller, Michael ;
Bernard, Brady ;
Hinoue, Toshinori ;
Laird, Peter W. ;
Curtis, Christina ;
Shen, Hui ;
Weisenberger, Daniel J. ;
Schultz, Nikolaus ;
Shen, Ronglai ;
Weinhold, Nils ;
Keiser, David P. ;
Bowlby, Reanne ;
Sipahimalani, Payal ;
Cherniack, Andrew D. ;
Getz, Gad ;
Liu, Yingchun ;
Noble, Michael S. ;
Pedamallu, Chandra ;
Sougnez, Carrie ;
Taylor-Weiner, Amaro ;
Akbani, Rehan ;
Lee, Ju-Seog ;
Liu, Wenbin ;
Mills, Gordon B. ;
Yang, Da ;
Zhang, Wei ;
Pantazi, Angeliki ;
Parfenov, Michael ;
Gulley, Margaret ;
Piazuelo, M. Blanca ;
Schneider, Barbara G. ;
Kim, Jihun ;
Boussioutas, Alex ;
Sheth, Margi ;
Demchok, John A. ;
Rabkin, Charles S. ;
Willis, Joseph E. ;
Ng, Sam ;
Garman, Katherine ;
Beer, David G. ;
Pennathur, Arjun ;
Raphael, Benjamin J. ;
Wu, Hsin-Ta ;
Odze, Robert ;
Kim, Hark K. ;
Bowen, Jay .
NATURE, 2014, 513 (7517) :202-209
[9]   Coinhibitory Pathways in Immunotherapy for Cancer [J].
Baumeister, Susanne H. ;
Freeman, Gordon J. ;
Dranoff, Glenn ;
Sharpe, Arlene H. .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34, 2016, 34 :539-573
[10]  
Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]